MYD88 and diffuse large B-cell lymphoma: In this study, HJ901, a synthetic ODN containing a sequence with CCT repeats, was found to exhibit a specific inhibitory role in TLR7/9 activation-induced innate immune responses and in reducing cell proliferation and tumor growth in ABC-DLBCL cell lines expressing the MyD88 L265P mutation.